Xanthine oxidase inhibitor and therapeutic treatment using same

Details Xanthine oxidase inhibitor and therapeutic treatment using same Xanthine oxidase inhibitor and therapeutic treatment using same

1980-10-28

1981-12-15

Cacciapaglia, Jr., Frank

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

544183, A61K 3153

Patent

active

043059422

ABSTRACT:
Therapeutic xanthine oxidase inhibitor composition containing as an active ingredient 3-dimethylamino-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzotria zine dihydrate of the formula ##STR1## Uratic diathesis in warm-blooded animals is therapeutically treated by administering the aforementioned xanthine oxidase inhibitor to such animals, e.g., human, either orally or by means of an injection, thereby inhibiting their xanthine oxidase activity.

REFERENCES:
patent: 3349088 (1967-10-01), Molnar et al.
Merck Index, 9th Ed., (1976) Entry No. 759.

Affiliated with

Also associated with

Rating

Xanthine oxidase inhibitor and therapeutic treatment using same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Xanthine oxidase inhibitor and therapeutic treatment using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine oxidase inhibitor and therapeutic treatment using same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1903967